HCA Healthcare, Inc.
NYSE:HCAMedical - Care Facilities
-$12.05 today
- Market cap
- $99.51B
- Beta
- 1.13
- P/E (TTM)
- 12.5
- EPS (TTM)
- $29.98
- Dividend yield
- 0.80%
Volume 1.60M
Average 1.37M
HCA Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
HCA Healthcare, Inc.NYSE: HCA
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows in line with its trailing trend
Q2 FY2026 depreciation & amortization of $944M rose 9.4% year over year, ahead of the +7.4% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 1.5% from the prior quarter. Over 3 fiscal years it compounded at +5.9% a year.
Context
- Depreciation & amortization amounted to 4.7% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +9.4% holds above the trailing-twelve-month pace of +7.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 3.52B USD
- Year-over-year change
- +6.4%
- 4-year CAGR
- +5.4%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.52B | +6.4% |
| FY2024 | 2024-12-31 | 3.31B | +7.6% |
| FY2023 | 2023-12-31 | 3.08B | +3.6% |
| FY2022 | 2022-12-31 | 2.97B | +4.1% |
| FY2021 | 2021-12-31 | 2.85B | — |
Depreciation & Amortization vs competitors
How HCA compares with its peers on the latest reported figures
- HCA's LTM Jun 2026 depreciation & amortization of $3.67B is the largest of the 6 companies compared; the peer median is $435M.
- Its year-over-year change of +7.4% is the 5th highest of 6, against a peer median of +9.4%.
- Depreciation & amortization amounts to 4.7% of revenue for HCA, versus a peer median of 2.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.67B | +7.4% | +5.9% | 4.7% | |
| LTM Jun 2026 | $893M | +9.4% | +0.9% | 4.1% | |
| LTM Jun 2026 | $641.16M | +7.5% | +2.1% | 3.5% | |
| LTM Mar 2026 | $435M | -8.6% | -7.3% | 2.0% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $162.49M | +10.4% | +4.1% | 2.5% |
| LTM Jun 2026 | $67.98M | +37.8% | +35.6% | 1.2% | |
| Peer median (excluding HCA) | $435M | +9.4% | +2.1% | 2.5% | |
Competitors are the stored peer set for HCA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.72B | 6.83B | 5.24B | 6.66B | 6.78B |
| Depreciation & Amortization | 2.85B | 2.97B | 3.08B | 3.31B | 3.52B |
| Deferred Income Tax | (70M) | 571M | 229M | 22M | 0 |
| Stock-Based Compensation | 440M | 341M | 0 | 360M | 0 |
| Change in Working Capital | (503M) | (1.15B) | (457M) | (106M) | 728M |
| Accounts Receivables | (962M) | (797M) | (935M) | (799M) | (94M) |
| Inventory | (540M) | (59M) | (126M) | 334M | (154M) |
| Accounts Payables | 999M | (296M) | 604M | 359M | 666M |
| Other Working Capital | 0 | 0 | 0 | 0 | 310M |
| Other Non-Cash Items | (1.48B) | (1.04B) | 1.34B | 269M | 1.6B |
| Operating Cash Flow | 8.96B | 8.52B | 9.43B | 10.51B | 12.64B |
| Capital Expenditures | (3.58B) | (4.4B) | (4.74B) | (4.88B) | (4.94B) |
| Acquisitions (Net) | 1.06B | 1.01B | (442M) | 62M | (128M) |
| Purchases of Investments | (117M) | (14M) | 0 | 0 | 0 |
| Sales of Investments | 117M | 14M | 0 | 0 | 72M |
| Other Investing Activities | (121M) | (7M) | (131M) | (120M) | 12M |
| Investing Cash Flow | (2.64B) | (3.39B) | (5.32B) | (4.93B) | (4.99B) |
| Debt Repayment | 3.26B | 3.29B | 1.3B | 3.21B | 3.21B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (8.22B) | (7B) | (3.81B) | (6.04B) | (10.07B) |
| Dividends Paid | (624M) | (653M) | (661M) | (690M) | (679M) |
| Other Financing Activities | (1.07B) | (1.29B) | (917M) | (1.06B) | (1.01B) |
| Financing Cash Flow | (6.66B) | (5.66B) | (4.09B) | (4.58B) | (8.55B) |
| Effect of Forex Changes | (3M) | (20M) | 7M | (1M) | 9M |
| Net Change in Cash | (342M) | (543M) | 27M | 998M | (893M) |
| Free Cash Flow | 5.38B | 4.13B | 4.69B | 5.64B | 7.69B |
HCA Healthcare, Inc.
NYSE:HCA
Intrinsic Alpha fair value
Locked
Current Price
$476.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.